Ángel Hernández-Hernández

7PUBLICATIONS
14CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersHaematologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 20, 2025
Altered PTPN13-β-catenin interaction by pathogenic mutations and involvement of this axis in B-cell receptor signalling.

David A Cabrera-Riofrío, Hongbing Li, Clara García-Calvo

|Jun 01, 2022
Germline PTPN13 mutations in patients with bone marrow failure and acute lymphoblastic leukemia.

Houtan Moshiri, David A Cabrera Riofrío, Yeon Jung Lim

|Jan 24, 2022
A 29-gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival.

Carla Ijurko, Nerea González-García, Purificación Galindo-Villardón

|Aug 27, 2021
Granuloma Formation in a Cyba-Deficient Model of Chronic Granulomatous Disease Is Associated with Myeloid Hyperplasia and the Exhaustion of B-Cell Lineage.

Rodrigo Prieto-Bermejo, Marta Romo-González, Alejandro Pérez-Fernández

|Jun 08, 2019
Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity.

Tamara Jiménez-Solas, Félix López-Cadenas, Irene Aires-Mejía

|Feb 16, 2019
SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: an alternative approach against acute myeloid leukemia.

Alejandro Pérez-Fernández, Guillermo López-Ruano, Rodrigo Prieto-Bermejo

Pageof 2

Frequent Collaborators

1 joint publications

Tamara Jiménez-Solas

1 joint publications

Juan Carlos Caballero-Berrocal

1 joint publications

María Díez-Campelo

1 joint publications

Rodrigo Prieto-Bermejo